Vir Biotechnology, Inc.
Infectious Disease Therapeutics · Artificial Intelligence
12open roles
$284kmedian advertised pay
16stories in the press
30technologies in use
Jobs
$236k – $329k per year · In office · 15+ years exp · Bachelor's Degree · San Francisco
GCP
Life Sciences
Good Clinical Practice
MedTech
CAPA
Apply
$163k – $228k per year · Hybrid · 12+ years exp · Bachelor's Degree · San Francisco
Apply
$236k – $330k per year · Remote (United States) · 13+ years exp · PhD · United States
Apply
Apply
$236k – $330k per year · In office · 15+ years exp · PhD · San Francisco
Apply
$204k – $284k per year · In office · 12+ years exp · Bachelor's Degree · San Francisco
Good Clinical Practice
Apply
$177k – $247k per year · In office · 7+ years exp · PhD · San Francisco
GCP
Apply
$152k – $190k per year · In office · Contractor · 10+ years exp · Bachelor's Degree · San Francisco
Apply
$160k – $218k per year · In office · Contractor · 8+ years exp · Bachelor's Degree · San Francisco
GCP
Life Sciences
GMP
GLP
MedTech
CAPA
Apply
$163k – $228k per year · In office · 10+ years exp · Bachelor's Degree · San Francisco
GMP
Apply
≈ $153k – $292k per year (Estimated) · Hybrid · Contractor · San Francisco
Python
PowerShell
Windows Server
AWS
Linux
Windows
Cybersecurity
Okta
Microsoft Entra ID
Active Directory
Apply
Apply
Salary insights
Compensation ranges based on this company's open jobs
Median
$284k
Typical range
$190k – $400k
Open positions
14
14
Jobs
Senior
42.9%
Architect
57.1%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 6 | $324k | $190k – $330k |
| Architect | 8 | $265k | $218k – $400k |
Highest paying role
SVP, Regulatory Affairs
$400k
Normalized to USD per year
All salaries at Vir Biotechnology, Inc.
By role, level and city, against the market · 14 jobs with pay
Visa sponsorship
3 ▼ 50%
H-1B filings in 12 months
2
Green card filings
$120k
Median offered salary
Who they sponsor
Biochemists and biophysicists
2
Statisticians
1
In the register as Vir Biotechnology, Inc., San Francisco, CA (+1 more)
Other sponsors in the same field
NOBL Q PRIVATE LIMITED 
BioCytics 
MetaCell 
Amalgam Rx
See 15 open roles Alert me
US Department of Labor · latest filing Jun 10, 2026 · Visa details by country
Growth
Hiring Momentum
25/100
Slowing
Open positions
15
0 opened / 0 closed in 30 days
Median time-to-fill
43 days
faster than 32% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Biotech
26% ▲
Early Careers
22% ▲
Science & Research
17%
HR
13% ▲
Data Science
4% ▼
DevOps
4% ▼
Actively hiring for Biotech (+3 in 30 days)
Tech stack
Technologies named in job postings at Vir Biotechnology, Inc. over the last 12 months, by layer, with the share of postings for each.
Technologies in use
30
Postings analysed
11
Stack modernity
87/100AI adopter
Languages
Python18%
Java9%
PowerShell9%
Databases
Amazon Redshift9%
Snowflake9%
Cloud & platforms
GCP36%
AWS18%
Active Directory9%
Databricks9%
AI & ML
Claude9%
Gemini9%
LLM9%
Sign in to see how your skills match this stack
Sign In
Full Vir Biotechnology, Inc. tech stack
30 technologies · by team · pay by technology · changes · similar stacks
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Alta PartnersVia a fund
Mubadala VenturesVia a fund
ARCH Venture PartnersVia a fund
DCVCVia a fund
GVVia a fund
569 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Can Vir Biotechnology (NASDAQ:VIR) deliver on its packed clinical calendar?
Vir Biotechnology (NASDAQ:VIR) advances dual-masked T-cell engagers and hepatitis programs as a busy clinical calendar draws attention.
Read more
Report
Vir Biotechnology's Chairman of the Board Sold 22,000 Company Shares. Here's What That Means for Investors.
Focused on immunology-based therapies for infectious diseases, this biotech company reported a notable insider sale in recent filings.
Read more
Report
Vir Biotechnology Announces First Patient Dosed in Phase 1 Clinical Trial of EGFR-Targeting PRO-XTEN Dual-Masked T-Cell Engager VIR-5525 for the Treatment of Solid Tumors
SAN FRANCISCO, July 24, 2025--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the first patient has been dosed in the Company's Phase 1 clinical trial evaluating VIR-5525, an investigational dual-masked T-cell engager (TCE) targeting EGFR (epid
Read more
Report
Where Vir Biotechnology Stands With Analysts
Across the recent three months, 4 analysts have shared their insights on Vir Biotechnology (NASDAQ:VIR), expressing a variety of opinions spanning from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments
Read more
Report
Vir Biotechnology (VIR) Soars 11.9%: Is Further Upside Left in the Stock?
Vir Biotechnology (VIR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn
Read more
Report
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2025 Financial Results
Vir Biotechnology, Inc., today provided a corporate update and reported financial results for the first quarter ended March 31, 2025. "The first quarter of 2025 marked significant progress in our mission of powering the immune system to transform lives, "
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
1
Countries
2
Busiest office
San Francisco
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
San Francisco
United States
HQ
San Francisco – Global HQ
15 open roles 21 posted in 90 days 27% engineering $264k Avg Salary
hires for Biotech, Early Careers, HR
1800 Owens Street
Bellinzona
Switzerland
Regional office
Bellinzona
Via dei Gaggini 3